Skip to main content
SpringerLink
Log in

Brentuximab-induced hand-foot syndrome in a Hodgkin lymphoma patient

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Swerdlow S et al (2008) WHO classification of tumors of hematopoietic and lymphoid tissues. International Agency for Research on, Cancer (IARC), pp 229–232

    Google Scholar 

  2. Furtado M, Rule S et al (2012) Emerging pharmacotherapy for relapsed or refractory Hodgkin’s lymphoma: focus on brentuximab. Vedotin Clin Med Insights Oncol 6:31–39

    CAS  PubMed  Google Scholar 

  3. Niels WCJ, van de Donk, E (2012) Brentuximab vedotin 4(4): 458–465

Download references

Author information

Authors and Affiliations

  1. Adult Hematology and BMT, Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia

    Jalil Ur Rehman, Mouhammed Kelta, Basim AlBeirouti & Radwi Ghazala Rashidhaider

  2. Pediatric Hematology/Oncology, Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia

    Bayoumy Mohamed

Authors
  1. Jalil Ur Rehman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mouhammed Kelta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Basim AlBeirouti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Radwi Ghazala Rashidhaider
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bayoumy Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jalil Ur Rehman.

Ethics declarations

Conflict of interest

Authors have no conflict of interests, and the work was not supported or funded by any drug company.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rehman, J.U., Kelta, M., AlBeirouti, B. et al. Brentuximab-induced hand-foot syndrome in a Hodgkin lymphoma patient. Ann Hematol 95, 509–510 (2016). https://doi.org/10.1007/s00277-015-2538-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2538-1

Keywords

Search

Navigation